Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin (GRAY-ZONE)

NCT03820466 PHASE3 TERMINATED

The study evaluates the effect of platelet inhibition and / or lipid lowering in non-ACS-patients with symptoms suggestive for ACS, and elevated high-sensitivity troponin values

Details

Lead sponsor	Dr. med. Mahir Karakas
Phase	PHASE3
Status	TERMINATED
Enrolment	68
Start date	Fri Feb 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Apr 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Acute Chest Syndrome

Interventions

• Aspirin
• Atorvastatin
• Placebo Aspirin
• Placebo Atorvastatin

Countries

Germany